Translational Development Acquisition Signs $3.9B M&A Deal with Prologium Holding Inc.
Translational Development Acquisition Corp. (TDAC) entered into an amendment to its existing merger agreement with ProLogium Holding Inc., a solid-state battery manufacturer. The amendment fixes the equity value of the transaction at $3.9 billion (based on a $3.8 billion enterprise value) and establishes a consolidation factor of 4.16 for ProLogium's recapitalization. The deal structure was also updated to replace share consolidation mechanics with a share exchange immediately prior to the closing of the business combination.
- Value
- $3.9B
- Counterparty
- Prologium Holding Inc.